Genes may determine who gets hooked or psychotic from cannabis
NCT ID NCT06058702
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study investigates how a person's genetic makeup influences their response to cannabis, including risk for addiction and psychosis. Healthy adults aged 21-60 receive either a very low or medium dose of THC (the active ingredient in cannabis) or a placebo intravenously. Researchers measure changes in mood, perception, thinking, and symptoms to see if certain genes predict stronger reactions. The goal is to better understand why some people develop cannabis use disorder or schizophrenia-related symptoms after using cannabis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Delta-9-THC (active ingredient in cannabis) given intravenously at very low and medium doses, compared to placebo
- What this could lead to
- If successful, this research could help identify genetic factors that make some people more vulnerable to cannabis addiction or psychosis, potentially guiding personalized prevention or treatment strategies.
- What could go wrong
- This is an early-phase study with a small sample, so findings may not apply broadly. The genetic links are complex and may not lead to clear clinical applications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West Haven Veterans Affairs Medical Center
RECRUITINGWest Haven, Connecticut, 06516, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a video call strengthen families facing schizophrenia?
- Virtual family therapy may tame schizophrenia symptoms — a trial investigates
- Could a Once-Every-Few-Weeks shot replace daily pills for schizophrenia?
- Can a tailored self-management program improve health outcomes for those with serious mental illness?
- PET scans reveal how antipsychotics target key brain receptors in schizophrenia
- Immune clues in schizophrenia: could inflammation subtypes guide treatment?